BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18254572)

  • 1. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; CastaƱeda O; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular disease and chronic renal failure: new insights.
    Nanayakkara PW; Gaillard CA
    Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in children with chronic renal failure.
    Flynn JT
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S84-90. PubMed ID: 16698298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
    Stenvinkel P
    Nephrol Ther; 2006 Jul; 2(3):111-9. PubMed ID: 16890135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan.
    Kagiyama S; Matsumura K; Ansai T; Soh I; Takata Y; Awano S; Sonoki K; Yoshida A; Takehara T; Iida M
    Hypertens Res; 2008 Nov; 31(11):2053-8. PubMed ID: 19098377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter.
    Neade T; Uribarri J
    Semin Dial; 2008; 21(4):331-7. PubMed ID: 18573134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
    Yetik-Anacak G; Catravas JD
    Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathogenesis of chronic kidney disease].
    Kashihara N; Satoh M
    Nihon Rinsho; 2008 Sep; 66(9):1671-7. PubMed ID: 18788393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early origins of cardiovascular disease in pediatric chronic kidney disease.
    Patel HP
    Ren Fail; 2010 Jan; 32(1):1-9. PubMed ID: 20113258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
    Ueda S; Yamagishi S; Kaida Y; Okuda S
    Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.